Japanese Bridging Study Conducted in the United States

NCT00947245 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus

Interventions

DRUG: BMS-791325
DRUG: BMS-791325
DRUG: BMS-791325
DRUG: BMS-791325
DRUG: BMS-791325
DRUG: BMS-791325
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo

Sponsor

Bristol-Myers Squibb